Results 21 to 30 of about 22,851 (227)

THROMBOPROPHYLAXIS;

The Professional Medical Journal, 2012
Maternal obesity (body mass index, BMI≥30kg/m²) is a global health problem. Significant evidence is available that it is directlyassociated with an increased risk of venous thromboembolic events in pregnancy and puerperium. Objective: This study aims to assess ourcurrent management protocols for thromboprophylaxis and to improve them according to ...
NAUSHEEN NABEEL, FAUZIA FAHIM, TALHA ABDUL HALIM   +2 more
openaire   +2 more sources

Edoxaban: an update on the new oral direct factor Xa inhibitor. [PDF]

, 2014
Edoxaban is a once-daily oral anticoagulant that rapidly and selectively inhibits factor Xa in a concentration-dependent manner. This review describes the extensive clinical development program of edoxaban, including phase III studies in patients with ...
Camm, AJ, Bounameaux, H, A. John Camm, Henri Bounameaux   +3 more
core   +1 more source

Hematologists’ awareness of venous thromboembolism in multiple myeloma: a national survey in China

Annals of Medicine, 2023
Background Venous thromboembolism (VTE) is one of the most common and severe complications of multiple myeloma (MM). The aim of this study was to learn about the current awareness regarding MM-associated VTE among Chinese hematologists.Methods A ...
Qun Li, Bo Zhang, Qianwen Cheng, Fei Zhao, Junying Li, Han Yan, Aoshuang Xu, Chunyan Sun, Yu Hu   +8 more
doaj   +1 more source

Thromboprophylaxis: medical recommendations and hospital programs [PDF]

, 2011
Venous thromboembolism (VTE) is the most preventable cause of in-hospital death. Hospital-related VTE is associated with over 50% of VTE episodes occurring either during or after hospitalization.
Barreto, Sandhi Maria, Caiafa, Jackson S., Rezende, Suely Meireles, de Bastos, Marcos   +3 more
core   +1 more source

Enhanced thromboprophylaxis in critically ill patients with COVID-19 infection

Thrombosis Update, 2021
Background: Patients with severe SARS-CoV-2 infection have been shown to have abnormal coagulation parameters and are at increased risk of thromboembolism. The optimal thromboprophylaxis regimen that minimizes thrombosis without increased risk of serious
R.L. Kummer, K.A. Considine, M.A. Rankin, L.M. Hubbard, T.S. Lam, L.T. Thornton, A.R. Lindsay, A.S. Ahiskali, J.W. Leatherman   +8 more
doaj   +1 more source

VTE prevention in medical inpatients - Current approach and controversies

Thrombosis Update, 2023
Hospitalisation with an acute medical illness represents a significant risk factor for venous thromboembolism. Identification of patients at high risk of VTE at hospital admission and provision of appropriate thromboprophylaxis is a key intervention to ...
Rachel E. Clapham, Elizabeth Marrinan, Lara N. Roberts   +2 more
doaj   +1 more source

Electronic alert system for improving appropriate thromboprophylaxis in hospitalized medical patients: a randomized controlled trial [PDF]

, 2017
Essentials Venous thromboembolism (VTE) prophylaxis in hospitalized medical patients remains inconsistent. We implemented an electronic alert system featuring a validated risk assessment model for VTE.
D. Spirk, A. Hager, R.P. Engelberger, Kucher, N, Hager, A, A.K. Stuck, Aujesky, D, D. Aujesky, Stuck, A K, Spirk, D, Spirk, David, Kucher, Nils, Engelberger, R P, Engelberger, Rolf P., N. Kucher, Aujesky, Drahomir, Stuck, Anna K.   +16 more
core   +1 more source

A multicentre study of thromboprophylaxis in pregnancy [PDF]

, 2017
Venous thromboembolism (VTE) is a leading cause of maternal mortality. The risk increases with increasing maternal age, mode of delivery and medical co-morbidities.
Higgins, John R., O\u27Shea, S., Noone, C., Crowley, Maeve P., O'Shea, S.   +4 more
core   +2 more sources

The Use of venous thromboembolism prophylaxis in relatioN to patiEnt risk profilINg (TUNE IN) Wave 3 study

South African Medical Journal
Background. Thromboprophylaxis significantly reduces the risk of venous thromboembolism (VTE) in hospitalised medical and surgical patients. Nonetheless, the implementation of thromboprophylaxis in South Africa (SA) and worldwide is low.
J Bassett, E Schapkaitz, B Jacobson
doaj   +1 more source

Thromboprophylaxis with dalteparin in medical patients: which patients benefit?

, 2007
It is unclear whether thromboprophylaxis produces a consistent risk reduction in different subgroups of medical patients at risk from venous thromboembolism.
Cohen, A. T., Leizorovicz, A., Olsson, Carl-Gustav, Vaitkus, P. T., Stu, Prevent Med Thromboprophylaxis, Goldhaber, S. Z., Turpie, A. G. G.   +6 more
core   +1 more source